GenesisCare

This week we held our Care to Shine Awards shining a light on those in our Australian team who care to make a difference to deliver the best possible life outcomes for our patients. More than 140 nominations were submitted nationally - such a wonderful appreciation of our team and their fantastic achievements. To each of our finalists and winners - Congratulations and thank you for everything you do at GenesisCare. #designingbettercare

GenesisCare was honoured to participate this week in a meaningful public information session at CanRevive, supporting those affected by prostate cancer. The session was a collaboration between GenesisCare, CanRevive and the St Vincent’s NELUNE Men’s Health Centre designed to support patients and carers in the Chinese speaking community. Event highlights included: ✔️ Precision treatment options: Insights about advanced radiation therapy treatment options, including the MRI-Linac. ✔️ Holistic support: Informative discussions on managing sexual, urinary, and mental health challenges, along with nutritional strategies for those undergoing hormone therapy. ✔️ Multilingual accessibility: Presentations were translated into Mandarin and Cantonese, helping to ensuring inclusivity for all attending. A heartfelt thank you to our incredible speakers for taking the time to support the community. CanRevive Inc. 更生會 The NELUNE Foundation St Vincent's Health Australia St Vincent’s Health Network Sydney #CancerCare #ProstateCancerAwareness #DesigningBetterCare #MensHealth Jeremy de Leon, Joseph O., David Crawford, Charles Tran, Ge Kai (Eunice) Ho

Exciting news for the South West Sydney & Southern Highlands communities! Lumus Imaging has opened their brand-new diagnostic imaging centre onsite at GenesisCare, Campbelltown. Their experienced team of Radiologists and Nuclear Medicine Physicians are offering a full range of advanced imaging services including: ✔️ X-Ray, CT, and MRI ✔️ Ultrasound ✔️ Interventional Procedures ✔️ Nuclear Medicine ✔️ PET-CT ✔️ Mammography ✔️ DEXA/BMD ✔️ Echocardiogram With extended hours and Saturday availability the new centre adds to the comprehensive range of cancer care services available onsite for the local and surrounding communities. #designingbettercare #cancercare

Did you know that the chance of surviving breast cancer for at least five years has increased from 78% in 1994 to 93% in 2020?1 Most breast cancers can be treated successfully, especially if detected early. Early detection and diagnosis significantly increase the chances of effective treatment and positive outcomes. Knowing your risk factors, staying aware of any changes, and maintaining regular screenings are essential steps for proactive breast health. If you're worried about your risk of getting breast cancer or any concerning symptoms you may have, we suggest contacting your GP or Specialist today. For more information, visit: https://lnkd.in/eDpVidi4 #breastcancerawarenessmonth #breastcancer #earlydetectionsaveslives 1. "Breast Cancer in Australia." Breast Cancer Network Australia, 2024, https://lnkd.in/g4JxHXnR. Accessed 16 Oct. 2024.

Last week, we attended and sponsored the welcome dinner at the 2024 International Breast Cancer Conference in Leura, Blue Mountains. It was an engaging and informative multidisciplinary breast cancer event, featuring some incredible local and international speakers, including a few of our own amazing doctors. A shout out to A/Prof Tim wang who presented on 'Palliation in Breast Care', A/Prof Gillian Lamoury who presented twice on 'Refinement of RT fields' and 'Is there still a role for reverse sequencing', and A/Prof Michael Ng who presented on 'Dissecting B51- does it change practice in 2024'. yvonne zissiadis, Nicola Forsyth and Julia Schulz, along with Sarah Wise from UTS and the Perth Specialist Breast Care surgeons, also presented a poster on: "Bundling and patient navigation in early-stage breast cancer care –interim findings of a 100-patient pilot study. Thanks to Marie Burke OAM for your welcome address at the conference dinner. To all our doctors, we're sure all of your talks were well received and your insights appreciated! Lastly, a big thanks to Samantha Redfearn and Moe Hallani for supporting this event onsite. #internationalbreastcancerconference2024 #designingbettercare

A fantastic joint initiative from La Roche-Posay Laboratoire Dermatologique and GenesisCare! This week our Campbeltown centre hosted a skin education evening for nurses in the Macarthur region. The event was specifically tailored for local nurses, providing invaluable insights into advancements in oncology and the prevention and treatment of skin toxicity associated with cancer therapy. It was a great opportunity for nurses to enhance their understanding of oncology treatments and guidelines for managing skin toxicities as well as improve their practice. Thanks to our expert panel who gave their time and expertise on the evening: 👨⚕️ Dr. Michael Cardoso Radiation Oncologist and Site Director of GenesisCare   👨⚕️ Professor Pablo Fernández-Peñas, Dermatologist and Head of the Department of Dermatology at Westmead Hospital   👩⚕️ Dr. Jessica Smith, Medical Oncologist with a keen interest in clinical trials Finally - a big thank you to all the local nurses who attended and helped make this event a success! We look forward to offering more educational opportunities tailored to your needs in the future. #designingbettercare #cancercare

Stereotactic Radiation Therapy (SRT) has gained significant media attention over the past few years due to advances in its precision and effectiveness. SRT and SABR (Stereotactic Ablative Radiation Therapy), a specialised form of SRT, specifically target tumours with high doses of radiation therapy, while limiting the dose to surrounding healthy organs, minimising the risks of side effects (1,2). Learn more about SABR and its use as a radiation therapy treatment for certain cancer types: https://lnkd.in/gUQDnSsy #designingbettercare #cancercare #radiationtherapy References: 1. Cancer Council Australia [website]. Understanding Radiation Therapy. Last updated Dec. 2021 [cited Sept. 2023]. Access: https://www.cancer.org.au 2. Tsang Maverick WK. Journal of Thoracic Disease 2016;8:S517–S527.

Did you know that it's Nuclear Medicine Week? GenesisCare is proud to offer Theranostics, delivered by an experienced team of Nuclear Medicine Physicians. Theranostics may be suitable for some patients who have not responded to other therapies or who have complex metastases. For more information on Theranostics treatment click on the video below or visit https://lnkd.in/gqE-fmhD. https://lnkd.in/gz-DiPp9

Welcoming our new Chief Operating Officer, Matthew Bellairs!   We are thrilled to have welcomed Matthew to GenesisCare Australia as our new Chief Operating Officer this week. With nearly two decades of experience in healthcare management, Matthew brings a wealth of knowledge and expertise to our team.   Matthew's healthcare journey began as a nuclear medicine technologist at Royal Brisbane Hospital and has since expanded to encompass both medical imaging and cardiology, culminating in his previous role as the Group Chief Operating Officer at Qscan Group. He has a strong track record in driving growth, enhancing operational efficiency, and establishing strategic partnerships.   Matthew shared: "I am excited to join GenesisCare, as the values deeply align with mine. I am motivated by the opportunity to contribute to a team dedicated to providing exceptional care, treatment, and innovative solutions in the healthcare industry."   Please join us in welcoming Matthew to the GenesisCare Executive Leadership Team. We look forward to achieving great things together! Pictured with GenesisCare CEO, Richard Lizzio.   #GenesisCare #Oncology #Leadership #Welcome #DesigningBetterCare

Esta es una llamada a la solidaridad con los pacientes de cáncer de páncreas con recursos económicos limitados y sin alternativa de tratamiento. La Fundación GenesisCare ha iniciado un Programa Onco-solidario que facilita el acceso a la tecnología radioterápica más innovadora para tratar el cáncer de páncreas.   Hasta ahora el tratamiento de cáncer de páncreas inoperable no tenía una alternativa de tratamiento. La extraordinaria precisión del equipamiento de vanguardia MRIdian® MR Linac ofrece radioterapia adaptativa guiada por resonancia magnética que permite tratar casos de cáncer de páncreas con resultados positivos de supervivencia.   Ofrecer a pacientes con recursos económicos limitados la oportunidad de este tratamiento es una esperanza de vida para ellos. Con la ayuda de todos, empresas y particulares, la Fundación GenesisCare podría aumentar el número de pacientes tratados.   Consulta todo sobre el Programa Onco-solidario de la Fundación GenesisCare en https://lnkd.in/ex7ZVcAK   Únete al programa y habrás colaborado en hacer posible la igualdad ante el cáncer.   #SoyOncosolidario #CáncerDePáncreas #GenesisCare #GenesisCareEs #FundaciónGenesisCare #MRIdian #MRLinac